Liquid Biopsy Detects ctDNA in 95% of Metastatic CRC Patients

▸ TREATMENT

A Japanese single-center study using Guardant360 CDx found circulating tumor DNA in 18 of 19 metastatic colorectal cancer patients, with a median turnaround time of 11 days and pathogenic alterations identified in 79% of cases. (Journal of the Anus, Rectum and Colon)